Adi K. Diab
Expertise in
3
conditions

Dr. Adi K. Diab

Internal Medicine
UT MD Anderson Cancer Center
1515 Holcombe Blvd, 
Houston, TX 
Expertise in
3
conditions
UT MD Anderson Cancer Center
1515 Holcombe Blvd, 
Houston, TX 

Overview

Adi Diab is a primary care provider, practicing in Internal Medicine in Houston, Texas.

Dr. Diab is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Grover's Disease, Necrosis, Interstitial Nephritis, and Viral Gastroenteritis.

He is actively involved in clinical research, co-authoring 142 peer reviewed articles and participating in 3 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in TX

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Choice
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

UT MD Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II Study to Assess the Safety and Efficacy of Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
A Phase II Study to Assess the Safety and Efficacy of Tocilizumab in Combination With Ipilimumab and Nivolumab in Patients With Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: March 06, 2026
Intervention Type: Biological
Study Drugs: Ipilimumab, Nivolumab, Tocilizumab
Study Phase: Phase 2
Phase II Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4 for Patients With Metastatic Melanoma
Phase II Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4 for Patients With Metastatic Melanoma
Enrollment Status: Completed
Publish Date: October 08, 2024
Intervention Type: Drug, Biological, Other
Study Drugs: Cyclophosphamide, Interleukin-2, Ipilimumab
Study Phase: Phase 2
A Randomized Phase 3 Comparison of IMO-2125 With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)
A Randomized Phase 3 Comparison of IMO-2125 With Ipilimumab Versus Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma (ILLUMINATE-301)
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drugs: Ipilimumab, IMO-2125
Study Phase: Phase 3
View 2 Less Clinical Trials

142 Total Publications

Integration of spatial single-cell proteomics and spatial metabolomics reveals tumor microenvironment predictive of immunotherapy response in mucosal melanoma.
Integration of spatial single-cell proteomics and spatial metabolomics reveals tumor microenvironment predictive of immunotherapy response in mucosal melanoma.
Journal: bioRxiv : the preprint server for biology
Published: May 07, 2026
Similar Doctors
Expertise in
17
conditions
Dr. Preetesh M. Jain
Internal Medicine
Expertise in
17
conditions
Dr. Preetesh M. Jain
Internal Medicine

UT MD Anderson Cancer Center

1515 Holcombe Blvd, 
Houston, TX 
 (0.1 miles away)
713-792-1101
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Preetesh Jain is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Jain is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Leukemia, Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.

Expertise in
26
conditions
Dr. Maro N. Ohanian
Internal Medicine
Expertise in
26
conditions
Dr. Maro N. Ohanian
Internal Medicine

University Of Texas MD Anderson Cancer Center

1515 Holcombe Blvd Unit 428, 
Houston, TX 
 (0.3 miles away)
713-792-8760
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Maro Ohanian is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Ohanian is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.

Expertise in
13
conditions
Dr. Shreyaskumar R. Patel
Internal Medicine
Expertise in
13
conditions
Dr. Shreyaskumar R. Patel
Internal Medicine

Office

1515 Holcombe Blvd # 450, 
Houston, TX 
 (0.1 miles away)
713-794-4632
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shreyaskumar Patel is a primary care provider, practicing in Internal Medicine in Houston, Texas. Dr. Patel is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Synovial Sarcoma, Gastrointestinal Stromal Tumor, Rhabdomyosarcoma, and Osteotomy.

Frequently Asked Questions about Dr. Adi K. Diab

How do I make an appointment with Dr. Adi K. Diab?

You can book an appointment with Dr. Adi K. Diab by calling their office at 713-792-2121. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Adi K. Diab a top-rated expert for Grover's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Adi K. Diab is classified as an Advanced expert for Grover's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Adi K. Diab specialize in?

While Dr. Adi K. Diab is a Internal Medicine, they have specific expertise in Grover's Disease, Necrosis, and Interstitial Nephritis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Adi K. Diab participate in research or clinical trials?

Yes. Dr. Adi K. Diab has published 142 articles and abstracts on conditions like Grover's Disease. You can view a list of Dr. Adi K. Diab's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Adi K. Diab accept my insurance?

Dr. Adi K. Diab accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 713-792-2121 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Diab's expertise for a condition
ConditionClose
      View All 31 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile